Skip to content

What Are the Side Effects of the RSV Vaccine in Older Adults?

5 min read

According to the CDC, older adults face a higher risk of severe outcomes from respiratory syncytial virus (RSV), including hospitalization. For those considering immunization, understanding what are the side effects of the RSV vaccine in older adults? is an important step toward making an informed health decision.

Quick Summary

Most older adults experience only mild, short-lived side effects from the RSV vaccine, such as injection site pain, fatigue, and headache, though rare neurological events have occurred and are closely monitored by health agencies.

Key Points

  • Common Side Effects are Mild: Most older adults experience mild, temporary reactions like injection site pain, fatigue, headache, and muscle aches, which typically resolve within a few days.

  • Rare Neurological Risks: In very rare cases, serious neurological conditions, including Guillain-Barré Syndrome (GBS), have been reported in older adults following RSV vaccination and are under continuous monitoring.

  • Benefit vs. Risk Assessment: The risks associated with a severe RSV infection in older adults generally far outweigh the minimal risks of vaccine side effects.

  • Monitoring and Reporting: Health agencies closely track vaccine safety, and recipients are encouraged to report adverse events to systems like VAERS.

  • Know When to Act: While most side effects are normal, it's crucial to know the signs of a serious reaction, like severe allergic or neurological symptoms, and seek immediate medical help if they occur.

In This Article

Understanding the Common Side Effects

Like many vaccinations, the RSV vaccine can cause a variety of side effects, most of which are mild and resolve on their own within a few days. These are normal signs that your immune system is learning to recognize and fight the virus.

Mild Injection Site Reactions

This category includes side effects that occur at the location of the shot. These are the most frequently reported symptoms across clinical trials and real-world monitoring:

  • Pain, swelling, or redness: The arm where the shot was given may feel sore or look red and swollen for a day or two.
  • Tenderness: The area can feel sensitive to the touch.

Systemic Side Effects

These are more widespread effects throughout the body. While they can feel unpleasant, they are typically not severe and are manageable with rest and over-the-counter medication:

  • Fatigue or tiredness: A general feeling of being worn down is a common immune response.
  • Headache: Many recipients report a mild to moderate headache following vaccination.
  • Muscle or joint pain: Aches in the body are another frequent systemic symptom.
  • Fever: A low-grade fever may develop.
  • Nausea or diarrhea: Some individuals may experience minor digestive issues.

Managing Common Symptoms at Home

Managing side effects is straightforward and can help you feel more comfortable after your shot. Here are some simple steps to take:

  1. For injection site pain or swelling, apply a clean, cool compress to the area for 10–20 minutes at a time.
  2. Use a heating pad or take a warm bath to help soothe muscle and joint aches.
  3. Stay hydrated by drinking plenty of fluids, especially if you develop a fever.
  4. Rest is key. Give your body time to build its immune response.
  5. If symptoms are bothersome, over-the-counter pain relievers like ibuprofen or acetaminophen can help, but always consult your doctor before taking new medication.

Understanding the Rare, Serious Risks

While the overwhelming majority of RSV vaccine side effects are mild, health authorities have identified and continue to monitor for rare but serious neurological conditions associated with vaccination, most notably Guillain-Barré Syndrome (GBS). It is crucial to understand these risks, but it is equally important to remember their rarity and to weigh them against the serious dangers posed by an RSV infection in older adults.

  • Guillain-Barré Syndrome (GBS): This is a rare disorder where the body's immune system attacks its own nerves, potentially leading to muscle weakness and, in severe cases, paralysis. Following the vaccine rollout, the FDA and CDC identified an increased risk of GBS after reviewing data from Medicare recipients. The risk is very small, but health providers are advised to discuss it with older patients.
  • Severe allergic reactions: As with any vaccine, a severe allergic reaction (anaphylaxis) is a very rare possibility, typically occurring within minutes to an hour of the injection. This is why you are often asked to stay for 15 minutes of observation after receiving a vaccine.

A Note on Clinical Trials and Post-Market Surveillance

Ongoing post-licensure safety surveillance by bodies like the FDA and CDC is critical for detecting extremely rare adverse events that may not show up in clinical trials. The identification and ongoing monitoring of GBS demonstrate this process at work, ensuring the safety of public health interventions. You can learn more about vaccine safety monitoring from organizations like the Centers for Disease Control and Prevention.

Comparing Arexvy and Abrysvo: Side Effect Profiles

Two primary RSV vaccines are available for older adults, Arexvy (by GSK) and Abrysvo (by Pfizer). While both vaccines have similar overall safety profiles, slight differences in reported side effect rates exist based on clinical trial data and post-market surveillance. It is important to discuss the specific product with your healthcare provider.

Side Effect Arexvy (GSK) - Common Abrysvo (Pfizer) - Common
Injection Site Pain Very common (>30%) Very common (>30%)
Fatigue Common (>10%) Common (>10%)
Headache Common (>10%) Common (>10%)
Muscle Pain (Myalgia) Common (>10%) Common (>10%)
Joint Pain (Arthralgia) Common (>10%) Common (>10%)
Nausea Less Common (1-10%) Less Common (1-10%)
Diarrhea Less Common (1-10%) Less Common (1-10%)

Note: This table provides a general comparison based on reported clinical data. Individual experience may vary. Your healthcare provider can provide specific details related to each vaccine.

Co-Administration with Other Vaccines

For convenience, older adults often receive the RSV vaccine at the same time as their annual flu shot or the latest COVID-19 booster. While this is generally considered safe, some studies and reports indicate that co-administration could potentially increase the likelihood or intensity of mild side effects, such as fever or fatigue, compared to receiving a single vaccine. Discussing the best approach for your personal health situation with your doctor is always recommended.

When to Contact Your Doctor

While the vast majority of side effects are not cause for alarm, you should contact your healthcare provider if you experience any of the following:

  • Symptoms of GBS: Seek immediate medical attention if you notice new or worsening weakness, tingling, or numbness in your hands and feet, or difficulty walking or moving your joints.
  • Signs of an allergic reaction: Call 9-1-1 if you experience hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness.
  • Severe or persistent side effects: If your fever is high, your injection site is significantly swollen, or other symptoms do not improve after a few days, it is wise to consult a doctor.

Weighing the Benefits vs. Risks

For older adults, the risk of serious complications from an RSV infection is significant. Infection can lead to pneumonia, breathing difficulties, and worsening of chronic health conditions. In contrast, the side effects of the RSV vaccine are generally mild and temporary, and serious adverse events are exceedingly rare. The consensus among health professionals is that for most older adults, the benefits of getting the vaccine far outweigh the potential risks. Your doctor is the best resource for a personalized assessment of your risk factors and overall health status.

Conclusion

Knowing what are the side effects of the RSV vaccine in older adults? is an important part of proactive health management. While mild and temporary side effects are common, they are a small price to pay for protection against a potentially dangerous infection. Rare serious neurological risks, while real, have been identified and are closely monitored by health organizations. The key takeaway is to have an open and informed conversation with your healthcare provider to decide what is best for your individual needs and to seek medical advice for any concerning symptoms post-vaccination.

Frequently Asked Questions

Most mild side effects, such as injection site soreness, fatigue, or a headache, usually last for only one to three days. Rare, serious side effects would manifest differently and require immediate medical attention.

The RSV vaccine is currently only approved for use in older adults (60+) and in infants, with different formulations. The side effect profile for older adults is established through clinical trials and monitoring in that specific age group.

Yes, co-administering the RSV vaccine with other vaccines is generally safe. However, some studies suggest that getting multiple shots at once might slightly increase the likelihood or intensity of mild side effects, like fever or fatigue.

Guillain-Barré Syndrome is a rare neurological disorder where the immune system attacks the nerves. A very small increase in GBS cases was observed in older adults after RSV vaccination during clinical trials and post-market surveillance. The risk is small, but health authorities advise discussing it with your doctor.

For common side effects like soreness or fatigue, rest and staying hydrated are often sufficient. Over-the-counter pain relievers can help with headaches and muscle aches. For any concerning or severe symptoms, you should contact your healthcare provider immediately.

Most normal reactions are mild and short-lived. Serious reactions, like a severe allergic reaction (anaphylaxis), will typically involve hives, swelling, or difficulty breathing, and require emergency medical care. Neurological symptoms like severe weakness or tingling are also indicators of a serious issue that warrants immediate medical review.

The RSV vaccine provides significant protection against severe disease, hospitalization, and death caused by RSV infection in older adults. For this population, the vaccine is considered a vital tool for preventing serious respiratory illness.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.